M-CSF as a therapeutic target in BRAF(V600E) melanoma resistant to BRAF inhibitors. Barcelo C, Siso P, de la Rosa I, Megino-Luque C, et al. Br J Cancer 2022 Jun 20. pii: 10.1038/s41416-022-01886.

Read + Share

Amedeo Smart

Independent Medical Education

Barcelo C, Siso P, de la Rosa I, Megino-Luque C, et al. M-CSF as a therapeutic target in BRAF(V600E) melanoma resistant to BRAF inhibitors. Br J Cancer 2022 Jun 20. pii: 10.1038/s41416-022-01886.
PMID: 35725813